Goldman Sachs Maintains Neutral on Doximity, Lowers Price Target to $28

Benzinga Newsdesk www.benzinga.com Negative 62.6%

Neg 62.6% Neu 0% Pos 0%

Goldman Sachs analyst David Roman maintains Doximity (NYSE:DOCS) with a Neutral and lowers the price target from $34 to $28.